Literature DB >> 2189163

Vasculopathy associated with the antiphospholipid antibody syndrome.

C A Bowles1.   

Abstract

Antiphospholipid antibodies including the false-positive serologic test for syphilis, the lupus circulating anticoagulant, and the anticardiolipin antibody can be associated with recurrent thrombotic events, recurrent fetal loss, and thrombocytopenia. A range of other possible clinical associations also exists, including neurologic events, skin lesions, and cardiac lesions. The pathology of these lesions and the pathophysiology are discussed. Treatment is controversial but when indicated is directed toward prevention of recurrent episodes using anticoagulants including antiplatelet agents, warfarin, and heparin as well as occasionally prednisone with or without immunosuppressive agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2189163

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  6 in total

1.  Polyarteritis nodosa and the antiphospholipid syndrome.

Authors:  R Schoonjans; B Van Vlem; S Weyers; F De Keyser; M Praet; J Versieck; A Elewaut
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

2.  Cogan's syndrome: a new possible complication of antiphospholipid antibodies?

Authors:  P Casoli; B Tumiati
Journal:  Clin Rheumatol       Date:  1995-03       Impact factor: 2.980

Review 3.  Vascular Manifestations in Antiphospholipid Syndrome (APS): Is APS a Thrombophilia or a Vasculopathy?

Authors:  Salma Siddique; Jessie Risse; Guillaume Canaud; Stéphane Zuily
Journal:  Curr Rheumatol Rep       Date:  2017-09-04       Impact factor: 4.592

4.  Lack of correlation between anticardiolipin antibodies and peripheral autonomic nerve involvement in systemic lupus erythematosus.

Authors:  M Magarò; L Mirone; L Altomonte; A Zoli; S Angelosante
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

5.  Skin ulcer as the presenting symptom of primary antiphospholipid syndrome--resolution with anticoagulant therapy.

Authors:  M Tishler; J Papo; M Yaron
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

Review 6.  Morphology of vascular, renal, and heart lesions in the antiphospholipid syndrome: relationship to pathogenesis.

Authors:  M C Amigo; R García-Torres
Journal:  Curr Rheumatol Rep       Date:  2000-06       Impact factor: 4.686

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.